Loncastuximab (Anti-CD19)

Loncastuximab (Anti-CD19) is a monoclonal antibody targeting CD19. It shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL). MW :144.38 KD.

• Supplier: Selleck Chemicals
• Product #: A3160
• Sku #: A3160-1mg*25